Thomas A. Mckee

Geneve, GE 1205, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

From tumor regression grading to interpretable endpoints in neoadjuvant oncology.

From tumor regression grading to interpretable endpoints in neoadjuvant oncology.

Journal: NPJ precision oncology

Published: March 16, 2026

Azacitidine-induced remission enables allogeneic transplantation in TET2/BCOR-mutant relapsed extranodal natural killer/T-cell lymphoma: a case report.

Azacitidine-induced remission enables allogeneic transplantation in TET2/BCOR-mutant relapsed extranodal natural killer/T-cell lymphoma: a case report.

Journal: Haematologica

Published: December 09, 2025

A robust classifier for the intrinsic consensus molecular subtypes in colorectal cancer.

A robust classifier for the intrinsic consensus molecular subtypes in colorectal cancer.

Journal: Journal of translational medicine

Published: July 17, 2025

Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian Cancer.

Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian Cancer.

Journal: JCO precision oncology

Published: July 02, 2025

Non-genetic remodeling drives leukemia propagation and reveals actionable vulnerabilities in acute myeloid leukemia.

Non-genetic remodeling drives leukemia propagation and reveals actionable vulnerabilities in acute myeloid leukemia.

Journal: Cell reports. Medicine

Published: June 20, 2025

Survival of Colon Cancer in a Population-Based Cohort Study: A Comprehensive Analysis of Location of the Primary Tumor.

Survival of Colon Cancer in a Population-Based Cohort Study: A Comprehensive Analysis of Location of the Primary Tumor.

Journal: Cancer medicine

Published: April 11, 2025

BRCA2 germline mutation carrier with five malignancies: a case report.

BRCA2 germline mutation carrier with five malignancies: a case report.

Journal: Hereditary cancer in clinical practice

Published: August 29, 2024

Reporting of somatic variants in clinical cancer care: recommendations of the Swiss Society of Molecular Pathology.

Reporting of somatic variants in clinical cancer care: recommendations of the Swiss Society of Molecular Pathology.

Journal: Virchows Archiv : an international journal of pathology

Published: August 07, 2024

Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models.

Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models.

Journal: Science translational medicine

Published: July 24, 2024

High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian Cancer.

High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian Cancer.

Journal: JCO precision oncology

Published: March 21, 2024

GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model.

GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model.

Journal: Frontiers in immunology

Published: March 06, 2024

Effectiveness of fractionated rituximab in preventing tumor lysis syndrome in aggressive B-cell lymphoma: Insights from real-life clinical practice.

Effectiveness of fractionated rituximab in preventing tumor lysis syndrome in aggressive B-cell lymphoma: Insights from real-life clinical practice.

Journal: Cancer reports (Hoboken, N.J.)

Published: October 06, 2023

Showing 1-12 of 58

Last Updated: 09/26/2026